HLF Q3'26 Earnings: EPS estimate is 0.62 USD

Herbalife (HLF) will report Q3'26 earnings on November 2, with revenue expected at $1.31B and EPS at $0.62, according to estimates.

Original reporting
Published Oct 30, 2026, 11:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 11:06 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
HLF Q3'26 Earnings: EPS estimate is 0.62 USD — source image
Decision brief

The 30-second read

$HLFNeutralMed
01

Why it matters

Consensus expectations (EPS $0.62, revenue $1.31B) and the exact release time can influence pre-positioning and after-hours volatility, but the text does not include any new earnings/guidance beyond the upcoming schedule.

02

Market read

Single-name earnings calendar item with consensus figures, useful for timing and expectation-setting rather than for a new fundamental catalyst.

03

What to watch

Traders may focus more on forward guidance, margin trajectory, and any commentary on demand or restructuring, none of which are included in this brief.

Relevance 4/10Novelty 3/10Timing: ahead of HLF’s Nov 2 after-hours Q3'26 earnings release

Background

The article states HLF will announce Q3'26 results on Nov 2 after the market closes, with results expected at 4:10 PM ET.

Company-level read

Ticker impact

$HLFNeutralMedium confidence
Context

HLF is scheduled to report Q3'26 results on Nov 2 after the close, with consensus EPS expected at $0.62 and revenue at $1.31B.

Expected impact

Likely volatility around the Nov 2 after-hours earnings release as traders compare reported results versus the $0.62 EPS and $1.31B revenue expectations.

Evidence & confidence

The article provides timing and consensus estimates but no actual results or new company-specific developments beyond the scheduled earnings disclosure.

Market effects

Limited sector read-through because the piece only provides a single company’s earnings timing and consensus estimates.

Minimal, as it is a US-listed single-name earnings setup without broader macro or cross-market catalysts.

Low, no international policy, supply chain, or cross-border transaction details are provided.

Counterpoint

If consensus is already widely known, the setup may not change expectations materially, making post-release reaction more dependent on guidance quality than on the headline EPS/revenue estimates.

Key entities

  • HLF

    Herbalife Ltd., scheduled to report Q3'26 results on Nov 2 after the close.

Related articles

$HLFMedAI 8/10

Herbalife Ltd (HLF) (Q3 2026) Earnings Call Highlights: Fifth Straight Quarter

Herbalife (HLF) reported Q3 2026 net sales of $1.4B, up 6% YoY, and adjusted EBITDA of $182M, beating guidance. Growth was driven by India and nutrition clubs, while EMEA and China saw declines. The company raised full-year sales guidance but expects gradual margin expansion. Interim CEO John DeSimone discussed product repositioning and new technology platforms. Operating cash flow rose 27% YoY, and net leverage improved to 2.0x.

$HLFHighAI 8/10

Why Herbalife Stock Is Up Today

Herbalife (HLF) shares rose 8% after Q3 results showed 6% revenue growth to $1.35B, with Asia Pacific up 18%. Adjusted net income increased 33% to $68.5M. The company raised full-year sales guidance and announced a $250M stock buyback program. According to interim CEO John DeSimone, growth is driven by 3M+ independent distributors.

$HLFMedAI 8/10

Herbalife Reports Q3 2026 Financial Results

Herbalife Ltd. reported Q3 2026 net sales of $1.35B, up 6% YoY, with regional growth varying. Adjusted EBITDA was $182.4M, EPS $0.55. Gross margin slightly declined to 77.3%. The company cited refinancing benefits and debt reduction. Management expects continued net sales growth.

$HLFHighAI 8/10

Herbalife (HLF) Q3 2026 Earnings Call Transcript

Herbalife (HLF) reported Q3 2026 net sales of $1.4B, up 6% YoY, and adjusted EBITDA of $182M, exceeding guidance. Interim CEO John DeSimone highlighted growth opportunities, including strengthening Nutrition Clubs and expanding the Bioniq brand. The company aims to enhance distributor support and technology capabilities.

$HLFMedAI 8/10

What Herbalife (HLF) Said on Its Q3 Earnings Call

Herbalife (HLF) reported Q3 sales growth of 5.1% in constant currency and 9% reported, with North America up 1.7%. FX reduced net sales by $21M. The company outlined priorities: nutrition clubs, tech platforms, and Bioniq brand growth. It expects Q4 sales growth of 0.5% to 4.5% and raised full-year sales guidance to 4.9% to 5.9%. Operating cash flow rose 27% YoY to $298M.